Jolanta S.
- Country
- Poland
- Department
- N-A
Research Overview
- Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of Oral Fenfluramine Hydrochloride in Participants with Rett Syndrome
- A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Clemizole Hydrochloride as Adjunctive Therapy in Patients with Lennox-Gastaut Syndrome
- A Phase 2, Prospective, Interventional, Open-Label, Multisite, Extension Study to Assess the Long-Term Safety and Tolerability of Soticlestat (TAK-935) as Adjunctive Therapy in Subjects with Developmental Epileptic Encephalopathies Including Dravet Syndrome, Lennox Gastaut Syndrome, CDKL5 Deficiency Disorder, and Chromosome 15 Duplication Syndrome (ENDYMION 1)
Data & Insights
Has run more than one trial at 13 of 94 partner sites.
Specializations
Paediatric Neurology and Developmental Epileptic Encephalopathies
Jolanta Strzelecka’s clinical research includes treatment-focused work in drug-resistant focal onset seizures, Rett syndrome, Lennox-Gastaut syndrome, Dravet syndrome, CDKL5 deficiency disorder, and other severe early-onset epileptic disorders.
- Refractory epilepsy
- Rare epileptic syndromes
- Seizure control
- Developmental epileptic encephalopathies
Her work is aligned with pediatric neurology care in Warsaw, with emphasis on therapies for complex seizure disorders and neurodevelopmental conditions.
Paediatric Haematology and Leukaemia
Her trial activity extends to acute lymphoblastic leukaemia, including research in children with high-risk disease and treatment-related risk reduction, as well as studies addressing immune-mediated cytopenias and thrombotic thrombocytopenic purpura.
- Acute lymphoblastic leukaemia
- Chronic idiopathic thrombocytopenic purpura
- Congenital thrombotic thrombocytopenic purpura
- JAK/STAT pathway
This area reflects involvement in pediatric blood disorders that require targeted immunologic and oncologic therapies.
Paediatric Gastroenterology and Inflammatory Bowel Disease
Her research landscape includes treatment of Crohn’s disease, with particular attention to inflammatory lesions in the upper gastrointestinal tract in children.
- Crohn’s disease
- Upper gastrointestinal inflammation
- Paediatric intestinal disease
The therapeutic focus in this field is centered on managing pediatric inflammatory disease affecting the oesophagus, stomach, and duodenum.
Paediatric Pulmonology and Fibrosing Interstitial Lung Disease
Jolanta Strzelecka is also involved in studies of childhood interstitial lung disease, including fibrosing forms that require long-term disease control and monitoring of respiratory safety outcomes.
- Childhood interstitial lung disease
- Fibrosing ILD
- Respiratory disease in children
This area connects her research activity with pediatric respiratory disorders that need specialized therapeutic management.
Paediatric Autoimmune and Metabolic Disorders
Her clinical trial profile includes studies in relapsing multiple sclerosis, presymptomatic type 1 diabetes, and hyperkalaemia, showing involvement in immune, endocrine, and electrolyte-related pediatric conditions.
- Relapsing multiple sclerosis
- Presymptomatic type 1 diabetes
- Hyperkalaemia
- Immune regulation
These interests place emphasis on pediatric therapies for autoimmune disease, early metabolic intervention, and correction of clinically significant electrolyte imbalance.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.